Atlas Trials

Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence

Clinical trial NCT04506398 · UNKNOWN

Trial details

NCT number
NCT04506398
Sponsor
RenJi Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma RecurrentLiver Transplant; Complications
Start date
2020-09-10
Primary completion
2021-08-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.